TriangleFOR PATIENTS · SOURCE READING
For patients with nodular lymphocyte–predominant Hodgkin lymphoma (NLPHL), treatment options also include:
Source: Hodgkin Lymphoma Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 27, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Treatment Option Overview
Continue within this section
Preserved source evidence · Independent clinical review pending · Not medical advice